HEADER TRANSPORT PROTEIN INHIBITOR 29-APR-13 2M7R TITLE NMDA RECEPTOR ANTAGONIST, CONANTOKIN BK-B, NMR, 20 STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CONANTOKIN BK-B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CON BK-B; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS TRANSPORT PROTEIN INHIBITOR EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.J.CURTICE,R.J.PLATT,J.J.SKALICKY,M.P.HORVATH,V.D.TWEDE REVDAT 2 12-MAR-14 2M7R 1 JRNL REVDAT 1 19-FEB-14 2M7R 0 JRNL AUTH R.J.PLATT,K.J.CURTICE,V.D.TWEDE,M.WATKINS,P.GRUSZCZYNSKI, JRNL AUTH 2 G.BULAJ,M.P.HORVATH,B.M.OLIVERA JRNL TITL FROM MOLECULAR PHYLOGENY TOWARDS DIFFERENTIATING JRNL TITL 2 PHARMACOLOGY FOR NMDA RECEPTOR SUBTYPES. JRNL REF TOXICON V. 81C 67 2014 JRNL REFN ISSN 0041-0101 JRNL PMID 24508768 JRNL DOI 10.1016/J.TOXICON.2014.01.016 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M7R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-13. REMARK 100 THE RCSB ID CODE IS RCSB103315. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.1 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.1 MM CONANTOKIN BK-B, REMARK 210 TRIFLUOROETHANOL/WATER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE CONANTOKIN BK-B IS POLYPEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CONANTOKIN BK-B REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 4 CGU A 3 32.34 -87.58 REMARK 500 6 CGU A 4 6.97 -69.32 REMARK 500 7 GLU A 2 22.73 -154.45 REMARK 500 7 CGU A 4 -14.18 -152.78 REMARK 500 8 GLU A 2 -70.43 -55.78 REMARK 500 9 GLU A 2 88.59 -69.92 REMARK 500 9 CGU A 3 -78.62 -88.75 REMARK 500 10 GLU A 2 -82.41 54.89 REMARK 500 15 GLU A 2 13.37 -151.79 REMARK 500 16 ALA A 8 56.35 -153.33 REMARK 500 17 CGU A 3 -60.04 -170.04 REMARK 500 18 CGU A 3 -73.91 -160.29 REMARK 500 20 GLU A 2 78.11 50.90 REMARK 500 20 CGU A 3 -53.86 -153.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19202 RELATED DB: BMRB DBREF 2M7R A 1 10 PDB 2M7R 2M7R 1 10 SEQRES 1 A 10 GLY GLU CGU CGU TYR SER CGU ALA ILE NH2 MODRES 2M7R CGU A 3 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2M7R CGU A 4 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 2M7R CGU A 7 GLU GAMMA-CARBOXY-GLUTAMIC ACID HET CGU A 3 17 HET CGU A 4 17 HET CGU A 7 17 HET NH2 A 10 3 HETNAM CGU GAMMA-CARBOXY-GLUTAMIC ACID HETNAM NH2 AMINO GROUP FORMUL 1 CGU 3(C6 H9 N O6) FORMUL 1 NH2 H2 N HELIX 1 1 CGU A 3 ILE A 9 1 7 LINK C GLU A 2 N CGU A 3 1555 1555 1.33 LINK C CGU A 3 N CGU A 4 1555 1555 1.33 LINK C CGU A 4 N TYR A 5 1555 1555 1.33 LINK C SER A 6 N CGU A 7 1555 1555 1.33 LINK C CGU A 7 N ALA A 8 1555 1555 1.33 LINK C ILE A 9 N NH2 A 10 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 108 0 4 1 0 0 0 6 0 0 0 1 END